Aster Capital Management (Difc) LTD Amicus Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 271 shares of FOLD stock, worth $2,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
271
Previous 2,486
89.1%
Holding current value
$2,336
Previous $26.6 Million
90.38%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
311Shares Held
283MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$252 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$210 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$209 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$200 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$134 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.42B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...